Report Detail
Global Cell-bridging Bispecific Antibodies Market Research Report 2022
- RnM4439968 |
- 16 May, 2022 |
- Global |
- 74 Pages |
- QYResearch |
- Pharma & Healthcare
Summary:
Bispecific T-cell engager (BiTE) stands out as a novel subclass of T-cell engaging bsAbs with promising clinical results in the treatment of cancers.
Industry Insights
Due to the COVID-19 pandemic, the global Cell-bridging Bispecific Antibodies market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Cell-bridging Bispecific Antibodies market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Cell-bridging Bispecific Antibodies landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
T Cell Engagers accounting for % of the Cell-bridging Bispecific Antibodies global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hematological Cancers segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Cell-bridging Bispecific Antibodies include Amgen and Immunocore etc. In terms of revenue, the global 3 largest players have a % market share of Cell-bridging Bispecific Antibodies in 2021.
This report focuses on Cell-bridging Bispecific Antibodies volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Cell-bridging Bispecific Antibodies market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Post-covid-19 Outlook
The readers in the section will understand how the Cell-bridging Bispecific Antibodies market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Segmental Outlook
Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).
Segment by Type
T Cell Engagers
NK Cell Engagers
Segment by Application
Hematological Cancers
Solid Tumors
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Scenario
In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Amgen
Immunocore
Frequently Asked Questions
Which product segment grabbed the largest share in the Cell-bridging Bispecific Antibodies market?
How is the competitive scenario of the Cell-bridging Bispecific Antibodies market?
Which are the key factors aiding the Cell-bridging Bispecific Antibodies market growth?
Which are the prominent players in the Cell-bridging Bispecific Antibodies market?
Which region holds the maximum share in the Cell-bridging Bispecific Antibodies market?
What will be the CAGR of the Cell-bridging Bispecific Antibodies market during the forecast period?
Which application segment emerged as the leading segment in the Cell-bridging Bispecific Antibodies market?
What key trends are likely to emerge in the Cell-bridging Bispecific Antibodies market in the coming years?
What will be the Cell-bridging Bispecific Antibodies market size by 2028?
Which company held the largest share in the Cell-bridging Bispecific Antibodies market?
Table of Contents
1 Cell-bridging Bispecific Antibodies Market Overview
- 1.1 Product Overview and Scope of Cell-bridging Bispecific Antibodies
- 1.2 Cell-bridging Bispecific Antibodies Segment by Type
- 1.2.1 Global Cell-bridging Bispecific Antibodies Sales Growth Rate Comparison by Type (2022-2028)
- 1.2.2 T Cell Engagers
- 1.2.3 NK Cell Engagers
- 1.3 Cell-bridging Bispecific Antibodies Segment by Application
- 1.3.1 Global Cell-bridging Bispecific Antibodies Sales Comparison by Application: (2022-2028)
- 1.3.2 Hematological Cancers
- 1.3.3 Solid Tumors
- 1.4 Global Cell-bridging Bispecific Antibodies Market Size Estimates and Forecasts
- 1.4.1 Global Cell-bridging Bispecific Antibodies Revenue 2017-2028
- 1.4.2 Global Cell-bridging Bispecific Antibodies Sales 2017-2028
- 1.4.3 Cell-bridging Bispecific Antibodies Market Size by Region: 2017 Versus 2021 Versus 2028
2 Cell-bridging Bispecific Antibodies Market Competition by Manufacturers
- 2.1 Global Cell-bridging Bispecific Antibodies Sales Market Share by Manufacturers (2017-2022)
- 2.2 Global Cell-bridging Bispecific Antibodies Revenue Market Share by Manufacturers (2017-2022)
- 2.3 Global Cell-bridging Bispecific Antibodies Average Price by Manufacturers (2017-2022)
- 2.4 Manufacturers Cell-bridging Bispecific Antibodies Manufacturing Sites, Area Served, Product Type
- 2.5 Cell-bridging Bispecific Antibodies Market Competitive Situation and Trends
- 2.5.1 Cell-bridging Bispecific Antibodies Market Concentration Rate
- 2.5.2 The Global Top 5 and Top 10 Largest Cell-bridging Bispecific Antibodies Players Market Share by Revenue
- 2.5.3 Global Cell-bridging Bispecific Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cell-bridging Bispecific Antibodies Retrospective Market Scenario by Region
- 3.1 Global Cell-bridging Bispecific Antibodies Retrospective Market Scenario in Sales by Region: 2017-2022
- 3.2 Global Cell-bridging Bispecific Antibodies Retrospective Market Scenario in Revenue by Region: 2017-2022
- 3.3 North America Cell-bridging Bispecific Antibodies Market Facts & Figures by Country
- 3.3.1 North America Cell-bridging Bispecific Antibodies Sales by Country
- 3.3.2 North America Cell-bridging Bispecific Antibodies Revenue by Country
- 3.3.3 United States
- 3.3.4 Canada
- 3.4 Europe Cell-bridging Bispecific Antibodies Market Facts & Figures by Country
- 3.4.1 Europe Cell-bridging Bispecific Antibodies Sales by Country
- 3.4.2 Europe Cell-bridging Bispecific Antibodies Revenue by Country
- 3.4.3 Germany
- 3.4.4 France
- 3.4.5 U.K.
- 3.4.6 Italy
- 3.4.7 Russia
- 3.5 Asia Pacific Cell-bridging Bispecific Antibodies Market Facts & Figures by Region
- 3.5.1 Asia Pacific Cell-bridging Bispecific Antibodies Sales by Region
- 3.5.2 Asia Pacific Cell-bridging Bispecific Antibodies Revenue by Region
- 3.5.3 China
- 3.5.4 Japan
- 3.5.5 South Korea
- 3.5.6 India
- 3.5.7 Australia
- 3.5.8 China Taiwan
- 3.5.9 Indonesia
- 3.5.10 Thailand
- 3.5.11 Malaysia
- 3.6 Latin America Cell-bridging Bispecific Antibodies Market Facts & Figures by Country
- 3.6.1 Latin America Cell-bridging Bispecific Antibodies Sales by Country
- 3.6.2 Latin America Cell-bridging Bispecific Antibodies Revenue by Country
- 3.6.3 Mexico
- 3.6.4 Brazil
- 3.6.5 Argentina
- 3.7 Middle East and Africa Cell-bridging Bispecific Antibodies Market Facts & Figures by Country
- 3.7.1 Middle East and Africa Cell-bridging Bispecific Antibodies Sales by Country
- 3.7.2 Middle East and Africa Cell-bridging Bispecific Antibodies Revenue by Country
- 3.7.3 Turkey
- 3.7.4 Saudi Arabia
- 3.7.5 UAE
4 Global Cell-bridging Bispecific Antibodies Historic Market Analysis by Type
- 4.1 Global Cell-bridging Bispecific Antibodies Sales Market Share by Type (2017-2022)
- 4.2 Global Cell-bridging Bispecific Antibodies Revenue Market Share by Type (2017-2022)
- 4.3 Global Cell-bridging Bispecific Antibodies Price by Type (2017-2022)
5 Global Cell-bridging Bispecific Antibodies Historic Market Analysis by Application
- 5.1 Global Cell-bridging Bispecific Antibodies Sales Market Share by Application (2017-2022)
- 5.2 Global Cell-bridging Bispecific Antibodies Revenue Market Share by Application (2017-2022)
- 5.3 Global Cell-bridging Bispecific Antibodies Price by Application (2017-2022)
6 Key Companies Profiled
- 6.1 Amgen
- 6.1.1 Amgen Corporation Information
- 6.1.2 Amgen Description and Business Overview
- 6.1.3 Amgen Cell-bridging Bispecific Antibodies Sales, Revenue and Gross Margin (2017-2022)
- 6.1.4 Amgen Cell-bridging Bispecific Antibodies Product Portfolio
- 6.1.5 Amgen Recent Developments/Updates
- 6.2 Immunocore
- 6.2.1 Immunocore Corporation Information
- 6.2.2 Immunocore Description and Business Overview
- 6.2.3 Immunocore Cell-bridging Bispecific Antibodies Sales, Revenue and Gross Margin (2017-2022)
- 6.2.4 Immunocore Cell-bridging Bispecific Antibodies Product Portfolio
- 6.2.5 Immunocore Recent Developments/Updates
7 Cell-bridging Bispecific Antibodies Manufacturing Cost Analysis
- 7.1 Cell-bridging Bispecific Antibodies Key Raw Materials Analysis
- 7.1.1 Key Raw Materials
- 7.1.2 Key Suppliers of Raw Materials
- 7.2 Proportion of Manufacturing Cost Structure
- 7.3 Manufacturing Process Analysis of Cell-bridging Bispecific Antibodies
- 7.4 Cell-bridging Bispecific Antibodies Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
- 8.1 Marketing Channel
- 8.2 Cell-bridging Bispecific Antibodies Distributors List
- 8.3 Cell-bridging Bispecific Antibodies Customers
9 Cell-bridging Bispecific Antibodies Market Dynamics
- 9.1 Cell-bridging Bispecific Antibodies Industry Trends
- 9.2 Cell-bridging Bispecific Antibodies Market Drivers
- 9.3 Cell-bridging Bispecific Antibodies Market Challenges
- 9.4 Cell-bridging Bispecific Antibodies Market Restraints
10 Global Market Forecast
- 10.1 Cell-bridging Bispecific Antibodies Market Estimates and Projections by Type
- 10.1.1 Global Forecasted Sales of Cell-bridging Bispecific Antibodies by Type (2023-2028)
- 10.1.2 Global Forecasted Revenue of Cell-bridging Bispecific Antibodies by Type (2023-2028)
- 10.2 Cell-bridging Bispecific Antibodies Market Estimates and Projections by Application
- 10.2.1 Global Forecasted Sales of Cell-bridging Bispecific Antibodies by Application (2023-2028)
- 10.2.2 Global Forecasted Revenue of Cell-bridging Bispecific Antibodies by Application (2023-2028)
- 10.3 Cell-bridging Bispecific Antibodies Market Estimates and Projections by Region
- 10.3.1 Global Forecasted Sales of Cell-bridging Bispecific Antibodies by Region (2023-2028)
- 10.3.2 Global Forecasted Revenue of Cell-bridging Bispecific Antibodies by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
- 12.1 Methodology/Research Approach
- 12.1.1 Research Programs/Design
- 12.1.2 Market Size Estimation
- 12.1.3 Market Breakdown and Data Triangulation
- 12.2 Data Source
- 12.2.1 Secondary Sources
- 12.2.2 Primary Sources
- 12.3 Author List
Summary:
Get latest Market Research Reports on Cell-bridging Bispecific Antibodies. Industry analysis & Market Report on Cell-bridging Bispecific Antibodies is a syndicated market report, published as Global Cell-bridging Bispecific Antibodies Market Research Report 2022. It is complete Research Study and Industry Analysis of Cell-bridging Bispecific Antibodies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
